ResPsyPark: Psychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's Disease

Sponsor

Central Hospital, Nancy, France (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05919628

Collaborator

(none)

Enrollment

Anticipated Duration (Days)

Study Details

Study Description

Brief Summary

Anxiodepressive symptoms are frequently observed in Parkinson's disease patients. These non motor psychiatric charateristics of the disease negatively impairs quality of life, and may impair well-being or therapeutical observance.

The objective of this study is to determine if psychological ressources are associated to anxiodepressive symptoms, to parkinson well-being and therapeutical observance. It will be interesting to determine if the presence of some - or multiple- psychological ressources could prevent patients from anxiety, depression, impaired well-being and impaired observance.

This study will analyse retrospectively psychological scalescompleted by 30 parkinson's disease patients through previous psychological interviews. The scales investigate anxiety, depression, well-being, psychological ressources, and therapeutical observance.

The results will highlight the importance of working on psychological ressources with Parkinson's disease patients through psychotherapy, in order to improve their well-being, positive emotions and maybe contribute to better therapeutical observance.

Condition or Disease	Intervention/Treatment	Phase
Parkinson's Disease	Other: ResPsyPark group

Detailed Description

The scales used are :

The SPANE
The PAS
The LOT-R
The SCS
The brief BDI
The SSAM
The HAD
The MAAS
An observance scale

Study Design

Study Type:

Observational

Anticipated Enrollment :

30 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Psychological Ressources as a Protective Factor for Anxiety-depression, Well-being and Therapeutical Observance in Parkinson's Disease.

Anticipated Study Start Date :

Jun 15, 2023

Anticipated Primary Completion Date :

Jun 15, 2023

Anticipated Study Completion Date :

Jun 30, 2023

Outcome Measures

Primary Outcome Measures

Study of the links between psychological ressources and anxiodepressive symptoms [At baseline]
Correlation and regression analysis between scores at the scales evaluating anxiety (PAS, HAD) and depression (BDI, HAD), and scores at the scales evaluating psychological ressources (LOT-R, SCS, SSAm, MAAS).

Secondary Outcome Measures

Study of the links between therapeutical observance and anxiodepressive symptoms [At baseline]
Correlation and regression analysis between scores at the scales evaluating anxiety (PAS, HAD) and depression (BDI, HAD), and score at the scale evaluating therapeutical observance (%).

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients with diagnosis of Parkinson's disease

Exclusion Criteria:

Patients with any other parkinsonian syndrome

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Mme Mylène MEYER, Psychologist, PhD, Central Hospital, Nancy, France

ClinicalTrials.gov Identifier:

NCT05919628

Other Study ID Numbers:

2023PI77

First Posted:

Jun 26, 2023

Last Update Posted:

Jun 26, 2023

Last Verified:

Jun 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Mme Mylène MEYER, Psychologist, PhD, Central Hospital, Nancy, France

psychological ressources

well-being

depression

anxiety

therapeutical observance

parkinson's disease

Additional relevant MeSH terms:

Parkinson Disease

Study Results

No Results Posted as of Jun 26, 2023